Risk of major cardiovascular events in patients with psoriasis receiving biologic therapies: a prospective cohort study

BACKGROUND: The cardiovascular safety profile of biologic therapies used for psoriasis is unclear. OBJECTIVES: To compare the risk of major cardiovascular events (CVEs; acute coronary syndrome, unstable angina, myocardial infarction and stroke) in patients with chronic plaque psoriasis treated with...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Eur Acad Dermatol Venereol
Autors principals: Rungapiromnan, W., Mason, K.J., Lunt, M., McElhone, K., Burden, A.D., Rutter, M.K., Warren, R.B., Griffiths, C.E.M., Ashcroft, D.M.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2019
Matèries:
Psoriasis
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7155017/
https://ncbi.nlm.nih.gov/pubmed/31633837
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdv.16018
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars